查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946982

2026年全球即时血液凝固检验市场报告

Point-of-Care (POC) Coagulation Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，即时血液凝固检验（POC​​）市场持续扩张，预计将从2025年的12.5亿美元成长到2026年的13亿美元，复合年增长率（CAGR）为4.2%。过去几年的成长要素包括：需要抗凝血治疗的心血管疾病盛行率上升；手术室和加护病房对快速血液凝固检验结果的需求不断增长；光学和机械式POC检测平台在临床上的早期应用；医院和诊所凝血监测的扩展；以及人们对照护现场诊断在优化治疗方面的认识不断提高。

预计未来几年，照护现场血液凝固检验（POC​​）市场将稳定成长，到2030年达到15.2亿美元，复合年增长率（CAGR）为4.1%。预测期内的成长要素包括：分散式和居家凝血监测的加速普及、电化学检测技术的日益广泛应用、急诊和创伤护理环境中检测量的增长、零售和竞标渠道的拓展，以及缩短检测结果等待时间和改善患者预后的重要性日益凸显。预测期内的主要趋势包括：重症监护和急诊护理环境中快速床边血液凝固检验的日益普及、POC凝血设备在抗凝血治疗监测中的应用日益广泛、携带式和手持式凝血分析仪的需求不断增长、居家医疗和门诊环境中血液凝固检验的日益普及，以及对用于实时临床决策支持的近乎即时检测的需求不断增长。

预计未来几年，心血管疾病发生率的不断上升将推动照护现场血液凝固检验（POC​​）市场的成长。心血管疾病（CVD）是指影响心臟和血管的多种疾病，包括冠状动脉疾病、脑血管疾病和周边动脉疾病。照护现场血液凝固检验能够即时反映患者的凝血状态，有助于心血管疾病的管理，使临床能够快速做出抗凝血治疗决策，并有助于降低心血管手术后出血併发症的风险。例如，根据美国疾病管制与预防中心（CDC）2024年10月发布的公告，到2023年，约六分之一的心血管相关死亡病例将发生在65岁以下的成年人中，心血管疾病导致的死亡总数将达到919,032人，总合所有死亡人数的三分之一。因此，心血管疾病发生率的上升正在推动照护现场血液凝固检验市场的成长。

为了获得竞争优势，照护现场血液凝固检验(POC) 市场的主要企业正致力于透过策略联盟创新互联的 POC 凝血解决方案。策略联盟是指两个或多个组织之间为实现互利共赢的通用目标而达成的正式协议，通常会结合互补的技术和专业知识。在 POC血液凝固检验领域，此类联盟能够整合数位健康平台、远端监测和互联功能，有助于改善临床决策并提升患者获得医疗保健服务的便利性。例如，2023 年 1 月，美国公司 Jana Care（该公司为其专有的数位健康平台开发生物标记检测）与瑞士公司罗氏诊断 (Roche Diagnostics) 建立了合作关係。罗氏诊断是一家专注于诊断测试、设备和数位医疗解决方案的瑞士公司。透过此次合作，两家公司旨在开发并提供用于筛检慢性肾臟病和心臟衰竭的POC 血液检测平台。该平台允许患者在家中进行血液检测，检测结果将以数位方式传输，并由临床医生远端审查。这提高了医疗服务的可近性，支持及时干预，并展示了互联的 POC 解决方案如何加强医疗服务和市场地位。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球即时血液凝固检验市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 在严重监护和急诊环境中，床边快速血液凝固检验的应用日益增加。
    • 床边凝血检测设备在抗凝血治疗监测的应用日益广泛
    • 携带式和手持式凝血分析仪正变得越来越受欢迎。
    • 扩大血液凝固检验在居家医疗和门诊环境的应用
    • 透过床边检测实现即时临床决策支援的需求日益增长

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 居家医疗环境
  • 急诊/加护病房
  • 其他的

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球即时血液凝固检验市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球即时血液凝固检验市场规模、对比及成长率分析
  • 全球即时血液凝固检验市场表现：规模与成长，2020-2025年
  • 全球即时血液凝固检验市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过技术
  • 光学技术、机械技术、电化学技术
  • 透过分销管道
  • 直接竞标，零售
  • 最终用户
  • 医院、诊所和居家医疗
  • 按类型细分：光学技术
  • 反射率检测法、萤光检测、比色检测
  • 按类型细分：机械技术
  • 机械振动、超音波检测
  • 按类型细分：电化学技术
  • 安培检测、电位检测、电导检测

第十章 区域与国家分析

  • 全球即时血液凝固检验市场：区域分析、预测及成长，2020-2025年、2025-2030年预测、2035年预测
  • 全球即时血液凝固检验市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 即时血液凝固检验市场：竞争格局及市场占有率（2024年）
  • 即时血液凝固检验市场：公司估值矩阵
  • 即时血液凝固检验市场：公司概况
    • Siemens Healthcare GmbH
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Sysmex Corporation

第37章：其他领先和创新企业

  • IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年即时血液凝固检验市场：提供新机会的国家
  • 2030年即时血液凝固检验市场：充满新机会的细分市场
  • 2030年即时血液凝固检验市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MPOCP02_G26Q1

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

Tariffs are impacting the point-of-care coagulation testing market by increasing import and raw material costs for sensors, optical components, microelectronics, and assay reagents used across optical, mechanical, and electrochemical testing platforms, leading to higher manufacturing and procurement expenses for hospitals, clinics, and home care providers. The effects are more evident in North America, Europe, and Asia-Pacific regions that depend on cross-border sourcing of handheld analyzers, strips, and disposable cartridges distributed through direct tender and retail channels. These higher landed costs have contributed to price sensitivity and delayed device adoption in some markets; however, tariffs are also encouraging localized assembly, regional reagent manufacturing, and supplier diversification, generating selective positive outcomes for domestic production ecosystems.

The point-of-care (poc) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (poc) coagulation testing market statistics, including point-of-care (poc) coagulation testing industry global market size, regional shares, competitors with a point-of-care (poc) coagulation testing market share, detailed point-of-care (poc) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (poc) coagulation testing industry. This point-of-care (poc) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (poc) coagulation testing market size has grown steadily in recent years. It will grow from $1.25 billion in 2025 to $1.3 billion in 2026 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases requiring anticoagulation therapy, increasing demand for rapid coagulation results in operating rooms and icus, early clinical adoption of optical and mechanical poc testing platforms, expansion of coagulation monitoring in hospital and clinic settings, growing awareness of point-of-care diagnostics for treatment optimization.

The point-of-care (poc) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing shift toward decentralized and home-based coagulation monitoring, rising utilization of electrochemical detection technologies, growing procedure volumes in emergency and trauma care environments, expanding access to retail and direct tender distribution channels, rising focus on reducing turnaround time and improving therapy outcomes. Major trends in the forecast period include rising adoption of rapid bedside coagulation testing in critical and emergency care settings, increasing use of poc coagulation devices for anticoagulation therapy monitoring, growing preference for portable and handheld coagulation analyzers, expansion of coagulation testing utilization in home care and outpatient settings, increasing demand for real-time clinical decision support through near-patient testing.

The increasing incidence of cardiovascular diseases is expected to drive the growth of the point-of-care (POC) coagulation testing market in the coming years. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing supports the management of cardiovascular diseases by delivering real-time insights into a patient's coagulation status, enabling prompt clinical decision-making regarding anticoagulation therapy and helping to reduce the risk of bleeding complications following cardiac surgery. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, in 2023, approximately one in six cardiovascular-related deaths occurred among adults younger than 65 years, with a total of 919,032 deaths attributed to cardiovascular disease, accounting for one in every three deaths. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the point-of-care (POC) coagulation testing market.

Major companies operating in the point-of-care (POC) coagulation testing market are focusing on innovating connected POC coagulation solutions through strategic collaborations to gain a competitive edge. Strategic collaboration refers to a formal agreement between two or more organizations to work jointly toward shared, mutually beneficial objectives, often combining complementary technologies and expertise. In the POC coagulation testing space, such collaborations enable the integration of digital health platforms, remote monitoring, and connectivity features that enhance clinical decision-making and patient access to care. For instance, in January 2023, Jana Care, a US-based company developing biomarker assays for its proprietary digital health platform, collaborated with Roche Diagnostics, a Switzerland-based company specializing in diagnostic tests, instruments, and digital healthcare solutions. Through this collaboration, the companies aimed to develop and distribute a point-of-care blood testing platform designed to screen for chronic kidney disease and heart failure. The platform allows patients to perform blood tests at home, with results transmitted digitally for remote review by clinicians, improving accessibility, supporting timely intervention, and demonstrating how connected POC solutions can strengthen care delivery and market positioning.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (poc) coagulation testing market are Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2025. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point-of-care (poc) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care (poc) coagulation testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care (poc) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Optical Technology; Mechanical Technology; Electrochemical Technology
  • 2) By Distribution Channel: Direct Tenders; Retail
  • 3) By End-User: Hospitals; Clinics; Home care
  • Subsegments:
  • 1) By Optical Technology: Reflectance Photometry; Fluorescence Detection; Colorimetric Detection
  • 2) By Mechanical Technology: Mechanical Oscillation; Ultrasonic Detection
  • 3) By Electrochemical Technology: Amperometric Detection; Potentiometric Detection; Conductometric Detection
  • Companies Mentioned: Siemens Healthcare GmbH; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Danaher Corporation; Sysmex Corporation; IDEXX Laboratories Inc.; Quidel Corporation; Werfen SA; Nihon Kohden Corporation; Horiba Ltd.; Hycel; Nova Biomedical Corporation; Haemonetics Corporation; Maccura Biotechnology Co. Ltd.; Helena Laboratories Corporation; Abaxis Inc.; ARKRAY Inc.; Radiometer Medical ApS; HemoSonics LLC; iLine Microsystems SL; Corgenix Medical Corporation; Quotient Limited; Micropoint Bioscience Inc.; Beijing Succeeder Technology Inc.; EKF Diagnostics Holdings plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Point-of-Care (POC) Coagulation Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Point-of-Care (POC) Coagulation Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Rapid Bedside Coagulation Testing In Critical And Emergency Care Settings
    • 4.2.2 Increasing Use Of Poc Coagulation Devices For Anticoagulation Therapy Monitoring
    • 4.2.3 Growing Preference For Portable And Handheld Coagulation Analyzers
    • 4.2.4 Expansion Of Coagulation Testing Utilization In Home Care And Outpatient Settings
    • 4.2.5 Increasing Demand For Real-Time Clinical Decision Support Through Near-Patient Testing

5. Point-of-Care (POC) Coagulation Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Home Care Settings
  • 5.4 Emergency And Critical Care Units
  • 5.5 Others

6. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-of-Care (POC) Coagulation Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Point-of-Care (POC) Coagulation Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Point-of-Care (POC) Coagulation Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Point-of-Care (POC) Coagulation Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Point-of-Care (POC) Coagulation Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-of-Care (POC) Coagulation Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-of-Care (POC) Coagulation Testing Market Segmentation

  • 9.1. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Optical Technology, Mechanical Technology, Electrochemical Technology
  • 9.2. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Tenders, Retail
  • 9.3. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Home care
  • 9.4. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Optical Technology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
  • 9.5. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Mechanical Technology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical Oscillation, Ultrasonic Detection
  • 9.6. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Electrochemical Technology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Amperometric Detection, Potentiometric Detection, Conductometric Detection

10. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

  • 10.1. Global Point-of-Care (POC) Coagulation Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Point-of-Care (POC) Coagulation Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

  • 11.1. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-of-Care (POC) Coagulation Testing Market

  • 12.1. China Point-of-Care (POC) Coagulation Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-of-Care (POC) Coagulation Testing Market

  • 13.1. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-of-Care (POC) Coagulation Testing Market

  • 14.1. Japan Point-of-Care (POC) Coagulation Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-of-Care (POC) Coagulation Testing Market

  • 15.1. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-of-Care (POC) Coagulation Testing Market

  • 16.1. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-of-Care (POC) Coagulation Testing Market

  • 17.1. South Korea Point-of-Care (POC) Coagulation Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-of-Care (POC) Coagulation Testing Market

  • 18.1. Taiwan Point-of-Care (POC) Coagulation Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-of-Care (POC) Coagulation Testing Market

  • 19.1. South East Asia Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-of-Care (POC) Coagulation Testing Market

  • 20.1. Western Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-of-Care (POC) Coagulation Testing Market

  • 21.1. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-of-Care (POC) Coagulation Testing Market

  • 22.1. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-of-Care (POC) Coagulation Testing Market

  • 23.1. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-of-Care (POC) Coagulation Testing Market

  • 24.1. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-of-Care (POC) Coagulation Testing Market

  • 25.1. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

  • 26.1. Eastern Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-of-Care (POC) Coagulation Testing Market

  • 27.1. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-of-Care (POC) Coagulation Testing Market

  • 28.1. North America Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-of-Care (POC) Coagulation Testing Market

  • 29.1. USA Point-of-Care (POC) Coagulation Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-of-Care (POC) Coagulation Testing Market

  • 30.1. Canada Point-of-Care (POC) Coagulation Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-of-Care (POC) Coagulation Testing Market

  • 31.1. South America Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-of-Care (POC) Coagulation Testing Market

  • 32.1. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-of-Care (POC) Coagulation Testing Market

  • 33.1. Middle East Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-of-Care (POC) Coagulation Testing Market

  • 34.1. Africa Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Segmentation By Distribution Channel, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-of-Care (POC) Coagulation Testing Market Regulatory and Investment Landscape

36. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

  • 36.1. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Point-of-Care (POC) Coagulation Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Point-of-Care (POC) Coagulation Testing Market Company Profiles
    • 36.3.1. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Sysmex Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

  • IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL

38. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

40. Point-of-Care (POC) Coagulation Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Point-of-Care (POC) Coagulation Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Point-of-Care (POC) Coagulation Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Point-of-Care (POC) Coagulation Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer